SBIR/STTR Research Award

High fidelity low cost manufacture of synthetic DNA

Award identifier 649da9b6c397521cae9c3043a2ebe649d4c83eef6753a637947d9b7cacc1bdf3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$731,491

Program and phase

SBIR · Phase II

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DNA Twopointo Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
G9S3SC8T5DM1
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The long term objective of this project is to develop technology to provide low-cost ( 90% and to reliably assemble these into genes. We aim to lower the cost of building block synthesis 3- to 10-fold by combining advanced chemistry with alternative engineering allowing a reduction in reaction volumes and reagent concentrations. It is essential for this application that this reduced cost is accompanied by an increase in quality: lower quality oligonucleotides assemble into genes that have increased error frequencies and thus require additional downstream manipulations and sequence verification, increasing the overall cost of production. We will therefore optimize synthesis on a 2- dimensional support to improve the stepwise coupling efficiency to >99.5%; in Phase I we demonstrated the feasibility of this by obtaining coupling efficiencies of 99.9% using modified chemistries and procedures. Small scale, low cost, high coupling efficiency oligonucleotide synthesis will allow greater flexibility in oligonucleotide gene building block design, remove the need for oligonucleotide purification prior to assembly into complete genes, reduce sequence confirmation costs and shorten order to delivery times. To achieve this, in Phase II we will develop an automated 96 channel instrument for synthesizing oligonucleotides with >90% purity. The machine will be integrated into our existing high throughput gene production line at DNA2.0. A low cost high fidelity oligonucleotide manufacturing process may have additional applications in related areas including diagnostic microarrays, real time PCR and RNAi-reagents.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

6 SBIR/STTR records share this UEI (2004–2008). Reported award amounts total $1,650,769. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.